Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.62 USD | -2.15% | +1.44% | +59.49% |
Mar. 21 | MediWound Ltd. Provides Revenue Guidance for the Year 2025 and 2026 | CI |
Mar. 21 | Transcript : MediWound Ltd., Q4 2023 Earnings Call, Mar 21, 2024 |
Evolution of the average Target Price on MediWound Ltd.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering MediWound Ltd.
HC Wainwright | |
Oppenheimer | |
Maxim | |
Wells Fargo Securities | |
Aegis Capital | |
Cowen |
EPS Revisions
- Stock Market
- Equities
- MDWD Stock
- Consensus MediWound Ltd.